Application of Hemostatic Agent “Haemoblock” for Pocket Hematoma Reduction. Design of the PEGAS study: a Multicenter Clinical Trial

Abstract

Pocket hematoma (PH) is a common complication of pacemaker implantations which prolongs hospitalization and may demand surgical revision in some cases. According to the data from different researchers PH rate varies from 2 to 7%. It depends on number of factors including a need for anticoagulation therapy. We present a review of design of multicenter clinical trial evaluating safety and efficacy of application of hemostatic agent “Haemoblock” for pocket hematoma reduction in patients taking oral anticoagulants.

Keywords

pacemaker pocket hematoma / oral anticoagulants / haemoblock

References

[1] Ilov N, Nechepurenko A, Abdulkadyrov A, et al. Arguments to apply epinephrine for pocket hematoma reduction. The MAITRE Study. J Atr Fibrillation. 2016;9(1):1391. DOI: 10.4022/jafib.1391

[2] Ilov N., Nechepurenko A., Abdulkadyrov A. et al. Arguments to apply epinephrine for pocket hematoma reduction. The MAITRE Study // J. Atr. Fibrillation. 2016. Vol. 9, No. 1. P. 1391. DOI: 10.4022/jafib.1391

[3] Notaristefano F, Angeli F, Verdecchia P, et al. Device-pocket hematoma after cardiac implantable electronic devices. Circ Arrhythm Electrophysiol. 2020;13(4):361–363. DOI: 10.1161/CIRCEP.120.008372

[4] Notaristefano F., Angeli F., Verdecchia P. et al. Device-Pocket hematoma after cardiac implantable electronic devices // Circ. Arrhythm. Electrophysiol. 2020. Vol. 13, No. 4. P. 361–363. DOI: 10.1161/CIRCEP.120.008372

[5] De Sensi F, Miracapillo G, Cresti A, et al. Pocket hematoma: a call for definition. Pacing Clin Electrophysiol. 2015;38(8):909–913. DOI: 10.1111/pace.12665

[6] De Sensi F., Miracapillo G., Cresti A. et al. Pocket hematoma: a call for definition // Pacing Clin. Electrophysiol. 2015. Vol. 38, No. 8. P. 909–913. DOI: 10.1111/pace.12665

[7] Essebag V, Verma A, Healey JS, et al. Clinically significant pocket hematoma increases long-term risk of device infection: BRUISE CONTROL INFECTION study. J Am Coll Cardiol. 2016;67(11): 1300–1308. DOI: 10.1016/j.jacc.2016.01.009

[8] Essebag V., Verma A., Healey J.S. et al. Clinically significant pocket hematoma in-creases long-term risk of device infection: BRUISE CONTROL INFECTION study // J. Am. Coll. Cardiol. 2016. Vol. 67, No. 11. P. 1300–1308. DOI: 10.1016/j.jacc.2016.01.009

[9] Sridhar ARM, Yarlagadda V, Yeruva MR, et al. Impact of haematoma after pacemaker and CRT device implantation on hospitalization costs, length of stay, and mortality: A popu-lation-based study. Europace. 2015;17(10):1548–1554. DOI: 10.1093/europace/euv075

[10] Sridhar A.R.M., Yarlagadda V., Yeruva M.R. et al. Impact of haematoma after pacemaker and CRT device implantation on hospitalization costs, length of stay, and mortali-ty: A population-based study // Europace. 2015. Vol. 17, No. 10. P. 1548–1554. DOI: 10.1093/europace/euv075

[11] Essebag V, Healey JS, Joza J, et al. Effect of direct oral anticoagulants, warfarin, and an-tiplatelet agents on risk of device pocket hematoma: Combined analysis of BRUISE CON-TROL 1 and 2. Circ Arrhythm Electrophysiol. 2019;12(10):e007545. DOI: 10.1161/CIRCEP.119.007545

[12] Essebag V., Healey J.S., Joza J. et al. Effect of direct oral anticoagulants, warfarin, and antiplatelet agents on risk of device pocket hematoma: Combined analysis of BRUISE CONTROL 1 and 2 // Circ. Arrhythm. Electrophysiol. 2019. Vol. 12, No. 10. P. e007545. DOI: 10.1161/CIRCEP.119.007545

[13] Birnie DH, Healey JS, Wells GA, et al. Pacemaker or Defibrillator Surgery without Inter-ruption of Anticoagulation. N Engl J Med. 2013;368(22):2084–2093. DOI: 10.1056/nejmoa1302946

[14] Birnie D.H., Healey J.S., Wells G.A. et al. Pacemaker or Defibrillator Surgery with-out Interruption of Anticoagulation // N. Engl. J. Med. 2013. Vol. 368, No. 22. P. 2084–2093. DOI: 10.1056/nejmoa1302946

[15] Sridhar ARM, Yarlagadda V, Kanmanthareddy A, et al. Incidence, predictors and out-comes of hematoma after ICD implantation: An analysis of a nationwide database of 85,276 patients. Indian Pacing Electrophysiol J. 2016;16(15):159–164. DOI: 10.1016/j.ipej.2016.10.005

[16] Sridhar A.R.M., Yarlagadda V., Kanmanthareddy A. et al. Incidence, predictors and outcomes of hematoma after ICD implantation: An analysis of a nationwide database of 85,276 patients // Indian Pacing Electrophysiol. J. 2016. Vol. 16, No. 15. P. 159–164. DOI: 10.1016/j.ipej.2016.10.005

[17] Lucevich O.Eh. Peculiarities of application of local hemostatic materials in surgery. Moscow Surgical Journal. 2016;(3(49)):12–20. (In Russ.).

[18] Луцевич О.Э. Oсобенности применения гемостатических материалов местного действия в хирургии // Московский хирургический журнал. 2016. № 3(49). С. 12–20.

[19] Tereshchenko SG, Plotkin AV, Mecheva LV. Intraorgan use of Hemoblock for prevention and arrest of bleedings in endoscopic excision of gastric polyps. Russian Sklifosovsky Journal Emergency Medical Care. 2019;8(1):30–34. DOI: 10.23934/2223-9022-2019-8-1-30-34

[20] Терещенко С.Г., Плоткин А.В., Мечева Л.В. Внутриорганное применение гемостатического средства «Гемоблок» для профилактики и остановки кровотечений при эндоскопическом удалении полипов желудка // Журнал им. Н.В. Склифосовского Неотложная медицинская помощь. 2019. Т. 8, № 1. С. 30–34. DOI: 10.23934/2223-9022-2019-8-1-30-34

[21] Tscholl V, Spann F, Moses J, et al. Prospective randomized study evaluating the effects of PerClot® (Polysaccharide Hemostatic System) application in patients with high bleeding risk undergoing cardiac rhythm device implantation. Int J Cardiol. 2017;248:84–91. DOI: 10.1016/j.ijcard.2017.08.038

[22] Tscholl V., Spann F., Moses J. et al. Prospective randomized study evaluating the effects of PerClot® (Polysaccharide Hemostatic System) application in patients with high bleeding risk undergoing cardiac rhythm device implantation // Int. J. Cardiol. 2017. Vol. 248. P. 84–91. DOI: 10.1016/j.ijcard.2017.08.038

[23] Reynbakh O, Akhrass P, Souvaliotis N, et al. Use of MPH hemostatic powder for elec-trophysiology device implantation reduces postoperative rates of pocket hematoma and infec-tion. Curr Med Res Opinion. 2018;34(10):1861–1867. DOI: 10.1080/03007995.2018.1476847

[24] Reynbakh O., Akhrass P., Souvaliotis N. et al. Use of MPH hemostatic powder for elec-trophysiology device implantation reduces postoperative rates of pocket hematoma and infec-tion // Curr. Med. Res. Opinion. 2018. Vol. 34, No. 10. P. 1861–1867. DOI: 10.1080/03007995.2018.1476847

[25] Degovtsov EN, Kolyadko PV, Kolyadko VP, Satinov AV. first results of a randomized controlled trial of hemoblock in patients with large incisional hernias. Russian Sklifosovsky Journal of Emergency Medical Care. 2019;8(4):430–436. (In Russ.). DOI: 10.23934/2223-9022-2019-8-4-430-436

[26] Деговцов Е.Н., Колядко П.В., Колядко В.П., Сатинов А.В. Первые результаты рандо-мизированного контролируемого исследования применения гемоблока у пациентов с большими вентральными послеоперационными грыжами // Журнал им. Н.В. Склифосовского Неотложная медицинская помощь. 2019. Т. 8, № 4. С. 430–436. DOI: 10.23934/2223-9022-2019-8-4-430-436

[27] Kolesov SV, Grin AA, Slinyakov LY, et al. Efficiency of using polyacrylic acid silver salt in decompression and stabilization surgery on the lumbar spine involving 1 to 3 segments. Spine Surgery. 2019;16(2):73–80. (In Russ.). DOI: 10.14531/ss2019.2.73–80

[28] Колесов С.В., Гринь А.А., Слиняков Л.Ю. и др. Эффективность использования серебряной соли полиакриловой кислоты при декомпрессионно-стабилизирующих операциях на поясничном отделе позвоночника с захватом 1–3 сегментов // Хирургия позвоночника. 2019. Т. 16, № 2. С. 73–80. DOI: 10.14531/ss2019.2.73–80

[29] Revishvili ASh, Shlyakhto EV, Popov SV, et al. Clinical recommendations for the use of electrophysiological study, catheter ablation and implantable cardiac electronic devices. Moscow; 2017. (In Russ.).

[30] Ревишвили А.Ш., Шляхто Е.В., Попов С.В. и др. Клинические рекомендации по проведению электрофизиологических исследований, катетерной абляции и применению имплантируемых антиаритмических устройств. М., 2017.

[31] Makarova NV, Durmanov SS, Kozlov AV, et al. Does early activa-tion of patients after pacemaker implantation affect the rate of post-intervention complications? Journal of Arrhythmology. 2013;(74):40–44. (In Russ.).

[32] Макарова Н.В., Дурманов С.С., Козлов А.В. и др. Влияет ли ранняя активизация пациентов после имплантации электрокардиостимуляторов на частоту послеоперационных осложнений? // Вестник аритмологии. 2013. № 74. С. 40–44.

Funding

Moscow Regional Scientific Research Institute of BloodМосковский областной научно-исследовательский институт крови

RIGHTS & PERMISSIONS

Nechepurenko A.A., Ilov N.N., Durmanov S.S., Shugaev P.L., Ivanchenko A.V., Suchkov I.A., Bsharat K.A., Lukin A.M., Medyanсeva L.G., Povarov V.O.